
Nortriptyline Capsules
Form: Capsules
Strength: 10 mg, 25 mg, 50 mg, 75 mg
Reference Brands: Pamelor®(US); Nortrilen®(EU)
Category: Antipsychotropic Drugs
In the United States, nortriptyline capsules are FDA-approved for the treatment of major depressive disorder (MDD). As a tricyclic antidepressant (TCA), it carries a Boxed Warning about increased risk of suicidal ideation in children, adolescents, and young adults. Regulatory compliance includes GMP manufacturing, bioequivalence studies for generics, and post-marketing safety surveillance. In the European Union, nortriptyline capsules are approved via national regulatory pathways for depression and off-label uses like chronic pain. EU guidelines require a valid Risk Management Plan (RMP), pharmacovigilance reporting, and labelling aligned with EMA safety standards. For global sourcing and compliant supply, visit Pharmatradz.com.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Risperidone Long-Acting Injection
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View DetailsZuclopenthixol Ong-Acting Im Injection (Depot)
Strength: 200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View DetailsZuclopenthixol Short-Acting Intramuscular Injection
Strength: 50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View DetailsZuclopenthixol Tablets
Strength: 10 mg, 25 mg, 40 mg
Form: Oral Tablets
Reference Brands: Clopixol®(EU)
View Details